1/2 Ganciclovir To Prevent Reactivation Of Cytomegalovirus In Patients With Acute Respiratory Failure And Sepsis
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Fred Hutchinson Cancer Center
Start Date
April 1, 2022
End Date
May 21, 2024
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Fred Hutchinson Cancer Center
Start Date
April 1, 2022
End Date
May 21, 2024